Hearing:
“Unsustainable Drug Prices: Findings from the Committee’s Drug Pricing Investigation and the Need for Structural Reforms”
Committee on Oversight and Reform
Friday, December 10, 2021 (10:00 AM)
Meeting has been postponed. Meeting will be rescheduled for a later date.
2154 RHOB
Washington, D.C.
*The hearing will convene in room 2154 of the Rayburn House Office Building and over Zoom, which has been approved by the House.
**This hearing has been rescheduled from 12/9 to 12/10 at 10:00am.
Witnesses
Ms. Rena Conti, PhD
Associate Professor, Department of Markets, Public Policy, and Law, Boston University, Questrom School of Business
Added
12/06/2021 at 08:38 PM
Mr. David Mitchell
President and Founder, Patients for Affordable Drugs
Added
12/06/2021 at 08:42 PM
Dr. Reshma Ramachandran
Physician-Fellow, Yale National Clinician Scholars Program, Co-Chair, Doctors for America Drug Affordability Action Team
Added
12/06/2021 at 08:38 PM
Ms. Mindy Salango
Patient Advocate with Type 1 Diabetes, Morgantown, West Virginia
Added
12/06/2021 at 03:32 PM
Ms. Erin Trish, PhD
Co-Director, University of Southern California Schaeffer Center, University of Southern California School of Pharmacy, Assistant Professor, Department of Pharmaceutical and Health Economics
Added
12/06/2021 at 08:42 PM
Support Documents
- Notice
[PDF]
- Memo
[PDF]
Added
12/06/2021 at 02:58 PM
- Updated Notice
[PDF]
Added
12/07/2021 at 01:51 PM
- Updated Notice - Hearing Postponed
[PDF]
Added
12/09/2021 at 11:11 AM
First Published:
December 2, 2021 at 10:13 PM
Last Updated:
December 9, 2021 at 11:11 AM